These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 29801680)

  • 1. Sarcoidosis-Like Granulomatous Reaction Associated With Pembrolizumab Immunotherapy.
    Gayá García-Manso I; García Ródenas MDM; Barroso Medel ME; Illán Gambín FJ
    Arch Bronconeumol (Engl Ed); 2018 Nov; 54(11):592-593. PubMed ID: 29801680
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary sarcoidosis induced by the anti-PD1 monoclonal antibody pembrolizumab.
    Cousin S; Toulmonde M; Kind M; Cazeau AL; Bechade D; Coindre JM; Italiano A
    Ann Oncol; 2016 Jun; 27(6):1178-1179. PubMed ID: 27091806
    [No Abstract]   [Full Text] [Related]  

  • 3. Granulomatous Tumoral Melanosis Associated With Pembrolizumab Therapy: A Mimicker of Disease Progression in Metastatic Melanoma.
    Woodbeck R; Metelitsa AI; Naert KA
    Am J Dermatopathol; 2018 Jul; 40(7):523-526. PubMed ID: 29924748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Rare Case of Pembrolizumab-Associated Granulomatous Panniculitis.
    Rozenova KA; Bridges AG
    Mayo Clin Proc; 2020 Nov; 95(11):2315-2316. PubMed ID: 33153618
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunotherapy-induced sarcoidosis in patients with melanoma treated with PD-1 checkpoint inhibitors: Case series and immunophenotypic analysis.
    Lomax AJ; McGuire HM; McNeil C; Choi CJ; Hersey P; Karikios D; Shannon K; van Hal S; Carr U; Crotty A; Gupta SK; Hollingsworth J; Kim H; Fazekas de St Groth B; McGill N
    Int J Rheum Dis; 2017 Sep; 20(9):1277-1285. PubMed ID: 28480561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Two cases of granuloma annulare under anti-PD1 therapy].
    Charollais R; Aubin F; Roche-Kubler B; Puzenat E
    Ann Dermatol Venereol; 2018 Feb; 145(2):116-119. PubMed ID: 29221649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients.
    Tetzlaff MT; Nelson KC; Diab A; Staerkel GA; Nagarajan P; Torres-Cabala CA; Chasen BA; Wargo JA; Prieto VG; Amaria RN; Curry JL
    J Immunother Cancer; 2018 Feb; 6(1):14. PubMed ID: 29433571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcoidosis-like Granulomatous Lung Reaction Associated with Anti-Programmed Death Receptor-1 Ligand Therapy.
    Balestra R; Benzaquen S; Wang J
    Ann Am Thorac Soc; 2017 Feb; 14(2):296-299. PubMed ID: 28146383
    [No Abstract]   [Full Text] [Related]  

  • 9. Rare case of delayed onset colitis due to immunotherapy for malignant melanoma.
    Sarofim M; Winn R
    ANZ J Surg; 2019 Oct; 89(10):E472-E473. PubMed ID: 30136350
    [No Abstract]   [Full Text] [Related]  

  • 10. Pembrolizumab-Related Sarcoid-Like Reaction Presenting as Reactivation of Quiescent Scars.
    McKenna MC; Molloy K; Crowther S; Feeney J; Gillis A; Connolly M; Kelleher F
    J Oncol Pract; 2018 Mar; 14(3):200-201. PubMed ID: 29300520
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune checkpoint blocker-related sarcoid-like granulomatous inflammation: a rare adverse event detected in lymph node aspiration cytology of patients treated for advanced malignant melanoma.
    Rodriguez EF; Lipson E; Suresh K; Cappelli LC; Monaco SE; Maleki Z
    Hum Pathol; 2019 Sep; 91():69-76. PubMed ID: 31279873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Thyroid Carcinoma During Treatment With Pembrolizumab in a Lung Cancer Patient.
    Gorospe L; García-Gómez-Muriel I; Pian-Arias HG; Gómez-Ramírez J; Rioja-Martín ME; Olmedo-García ME; Garrido-López P; Muñoz-Molina GM; Mezquita L
    Ann Thorac Surg; 2020 Jun; 109(6):e397-e399. PubMed ID: 31846639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy-induced Addison's disease: A rare, persistent and potentially lethal side-effect.
    Hescot S; Haissaguerre M; Pautier P; Kuhn E; Schlumberger M; Berdelou A
    Eur J Cancer; 2018 Jul; 97():57-58. PubMed ID: 29731229
    [No Abstract]   [Full Text] [Related]  

  • 14. Bullous pemphigoid in elderly woman affected by non-small cell lung cancer treated with pembrolizumab: A case report and review of literature.
    Cosimati A; Rossi L; Didona D; Forcella C; Didona B
    J Oncol Pharm Pract; 2021 Apr; 27(3):727-733. PubMed ID: 32772795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed Pembrolizumab-Associated Sarcoidosis.
    Valasapalli S; Aslam H; Younes AI; Muzaffar M
    Am J Ther; 2024 Jul-Aug 01; 31(4):e465-e468. PubMed ID: 38976531
    [No Abstract]   [Full Text] [Related]  

  • 16. Post-shingles granulomatous dermatosis related to anti-programmed cell death 1.
    Assi T; Danu A; Mateus C; Robert C; Michot JM; Ibrahim T; Lazarovici J; Ghez D; Rossignol J; Dartigues P; Terroir-Cassou-Mounat M; Ribrag V
    Immunotherapy; 2019 May; 11(7):591-598. PubMed ID: 30943861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pembrolizumab-Induced Extensive Panniculitis and Nevus Regression: Two Novel Cutaneous Manifestations of the Post-immunotherapy Granulomatous Reactions Spectrum.
    Burillo-Martinez S; Morales-Raya C; Prieto-Barrios M; Rodriguez-Peralto JL; Ortiz-Romero PL
    JAMA Dermatol; 2017 Jul; 153(7):721-722. PubMed ID: 28467548
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypothalamic expression of PD-L1: does it mediate hypothalamitis?
    Iervasi E; Strangio A; Saverino D
    Cell Mol Immunol; 2019 Jun; 16(6):625-626. PubMed ID: 30979971
    [No Abstract]   [Full Text] [Related]  

  • 19. Vasoactive Intestinal Peptide in Checkpoint Inhibitor-Induced Pneumonitis.
    Frye BC; Meiss F; von Bubnoff D; Zissel G; Müller-Quernheim J
    N Engl J Med; 2020 Jun; 382(26):2573-2574. PubMed ID: 32579820
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulmonary sarcoid-like granulomatosis induced by ipilimumab.
    Berthod G; Lazor R; Letovanec I; Romano E; Noirez L; Mazza Stalder J; Speiser DE; Peters S; Michielin O
    J Clin Oncol; 2012 Jun; 30(17):e156-9. PubMed ID: 22547608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.